NNVC - NanoViricides, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 514.91M
Enterprise Value 314.48M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.45
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.82

Trading Information

Stock Price History

Beta (3Y Monthly) 1.72
52-Week Change 3-47.21%
S&P500 52-Week Change 34.18%
52 Week High 30.6800
52 Week Low 30.1600
50-Day Moving Average 30.2232
200-Day Moving Average 30.2544

Share Statistics

Avg Vol (3 month) 3103.56k
Avg Vol (10 day) 3181.87k
Shares Outstanding 576.9M
Float 54.63M
% Held by Insiders 128.05%
% Held by Institutions 15.03%
Shares Short (Aug 15, 2019) 4355.21k
Short Ratio (Aug 15, 2019) 44.07
Short % of Float (Aug 15, 2019) 40.66%
Short % of Shares Outstanding (Aug 15, 2019) 40.46%
Shares Short (prior month Jul 15, 2019) 4416.34k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3Sep 24, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2019
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-33.83%
Return on Equity (ttm)-59.61%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.96M
Net Income Avi to Common (ttm)-8.42M
Diluted EPS (ttm)-0.1200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.56M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.99
Book Value Per Share (mrq)0.14

Cash Flow Statement

Operating Cash Flow (ttm)-6.8M
Levered Free Cash Flow (ttm)-2.32M